Literature DB >> 12220696

Activation of the tissue kallikrein-kinin system in stroke.

Simone Wagner1, Pamela Kalb, Martina Lukosava, Ulrich Hilgenfeldt, Markus Schwaninger.   

Abstract

Edema formation is a major problem in large ischemic infarcts, and the underlying breakdown of the blood-brain barrier is only incompletely understood. Here, we report that the tissue kallikrein-kinin system, which influences the permeability of the blood-brain barrier, is activated in stroke. In 22 patients with large infarcts in the territory of the middle cerebral artery, we found elevated plasma concentrations of the tissue kinin kallidin. The data suggest that further studies on a possible role of kinin receptor antagonists on edema after stroke are warranted. Copyright 2002 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12220696     DOI: 10.1016/s0022-510x(02)00208-3

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  14 in total

Review 1.  Candidate-based proteomics in the search for biomarkers of cardiovascular disease.

Authors:  Leigh Anderson
Journal:  J Physiol       Date:  2004-12-20       Impact factor: 5.182

Review 2.  Involvement of bradykinin in brain edema development after ischemic stroke.

Authors:  Marina Dobrivojević; Katarina Špiranec; Aleksandra Sinđić
Journal:  Pflugers Arch       Date:  2014-04-23       Impact factor: 3.657

Review 3.  Implication of the Kallikrein-Kinin system in neurological disorders: Quest for potential biomarkers and mechanisms.

Authors:  Amaly Nokkari; Hadi Abou-El-Hassan; Yehia Mechref; Stefania Mondello; Mark S Kindy; Ayad A Jaffa; Firas Kobeissy
Journal:  Prog Neurobiol       Date:  2018-01-31       Impact factor: 11.685

4.  TRPV1 activation results in disruption of the blood-brain barrier in the rat.

Authors:  De-En Hu; Alexander S Easton; Paul A Fraser
Journal:  Br J Pharmacol       Date:  2005-10       Impact factor: 8.739

5.  Novel contact-kinin inhibitor sylvestin targets thromboinflammation and ameliorates ischemic stroke.

Authors:  Zhiye Zhang; Chuanbin Shen; Mingqian Fang; Yajun Han; Chengbo Long; Weihui Liu; Min Yang; Ming Liu; Dengdeng Zhang; Qiqi Cao; Xue Chen; Yaqun Fang; Qiumin Lu; Zongliu Hou; Yaxiong Li; Zhenze Liu; Xi Lei; Heyu Ni; Ren Lai
Journal:  Cell Mol Life Sci       Date:  2022-04-13       Impact factor: 9.261

6.  The powerful neuroprotective action of C1-inhibitor on brain ischemia-reperfusion injury does not require C1q.

Authors:  Maria Grazia De Simoni; Emanuela Rossi; Claudio Storini; Simone Pizzimenti; Cinara Echart; Luigi Bergamaschini
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

7.  Activation profiles of human kallikrein-related peptidases by proteases of the thrombostasis axis.

Authors:  Hyesook Yoon; Sachiko I Blaber; D Michael Evans; Julie Trim; Maria Aparecida Juliano; Isobel A Scarisbrick; Michael Blaber
Journal:  Protein Sci       Date:  2008-08-12       Impact factor: 6.725

8.  LF 16-0687 Ms, a bradykinin B2 receptor antagonist, reduces ischemic brain injury in a murine model of transient focal cerebral ischemia.

Authors:  Li Ding-Zhou; Isabelle Margaill; Bruno Palmier; Didier Pruneau; Michel Plotkine; Catherine Marchand-Verrecchia
Journal:  Br J Pharmacol       Date:  2003-08       Impact factor: 8.739

Review 9.  Bradykinin B2 receptor antagonism: a new direction for acute stroke therapy?

Authors:  Christopher G Sobey
Journal:  Br J Pharmacol       Date:  2003-08       Impact factor: 8.739

10.  Remodeling of motor cortex function in acute cerebral infarction patients following human urinary kallidinogenase: A functional magnetic resonance imaging evaluation after 6 months.

Authors:  Xuezhu Song; Lixin Han; Yan Liu
Journal:  Neural Regen Res       Date:  2012-04-15       Impact factor: 5.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.